David Eansor
2018
In 2018, David Eansor earned a total compensation of $1.6M as Senior Vice President Biotechnology at Bio-Techne, a 18% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $403,181 |
|---|---|
| Option Awards | $543,753 |
| Salary | $455,000 |
| Stock Awards | $181,248 |
| Other | $8,100 |
| Total | $1,591,282 |
Eansor received $543.8K in option awards, accounting for 34% of the total pay in 2018.
Eansor also received $403.2K in non-equity incentive plan, $455K in salary, $181.2K in stock awards and $8.1K in other compensation.
Rankings
In 2018, David Eansor's compensation ranked 6,879th out of 14,244 executives tracked by ExecPay. In other words, Eansor earned more than 51.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,879 out of 14,244 | 52nd |
Division Manufacturing | 2,639 out of 5,765 | 54th |
Major group Chemicals And Allied Products | 995 out of 2,128 | 53rd |
Industry group Drugs | 836 out of 1,817 | 54th |
Industry Biological Products, Except Diagnostic Substances | 160 out of 339 | 53rd |
Source: SEC filing on September 9, 2019.
Eansor's colleagues
We found four more compensation records of executives who worked with David Eansor at Bio-Techne in 2018.